Vista, Others Drop Claims In Neurontin Case V. Pfizer

Law360, New York (March 26, 2009, 12:00 AM EDT) -- Five more end-payor plaintiffs, including Vista HealthPlan Inc., have voluntarily dismissed all claims against Pfizer Inc. in a consolidated class action that accused the pharmaceutical giant of a scheme to delay generic competition for the epilepsy drug Neurontin.

Vista HealthPlan, a painters union and three individual consumer plaintiffs lodged stipulations of voluntary dismissal on Tuesday in the U.S. District Court for the District of New Jersey, where litigation against Pfizer and its Warner-Lambert Co. subsidiary has been pending since 2002.

According to the stipulations, the end-payor...
To view the full article, register now.